Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Finasteride causes harmful organ changes in female mice.

Early hair loss may be linked to metabolic syndrome.

There is no significant link between metabolic syndrome and alopecia areata.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Skin tags may be linked to metabolic syndrome.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

The method can measure vitamin B3 levels in human hair accurately.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

People with Alopecia Areata have a higher risk of heart-related health issues.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Androgenetic alopecia patients have a higher risk of metabolic syndrome.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.